Search results
Results from the WOW.Com Content Network
Breakthrough T1D was founded to support and accelerate breakthroughs in medical science to cure, prevent, and treat type 1 diabetes and its complications. These goals are pursued both through scientific research and public advocacy campaigns. [19] [20] [21]
A woman with type 1 diabetes started producing her own insulin less than 3 months after receiving an injection of a stem-cell derived treatment. She remained free from insulin injections 1 year ...
The potential for creating new types of cells carries risks, but for someone with the chronic disease, the potential for a cure is a miracle. Cure for type-1 diabetes closer to reality through ...
The Juvenile Diabetes Cure Alliance (JDCA) is a registered 501(c)(3) non-profit organization dedicated to developing a Practical Cure for type 1 diabetes.The organization advocates for increasing type 1 diabetes cure research and publishes reports on a variety of related topics, including research progress, fundraising utilization, and donor priorities.
Zepbound, a new version of the company’s popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday, Nov. 8, 2023. (AP Photo/Darron Cummings, File)
Donislecel, sold under the brand name Lantidra, is a cellular therapy medication used for the treatment of type 1 diabetes. [3] [5] Donislecel is an allogeneic (donor) pancreatic islet cellular therapy made from deceased donor pancreatic cells. Donislecel is administered as a single infusion into the hepatic (liver) portal vein. [5]
This evidence convinced most physicians who specialize in diabetes care that an important goal of treatment is to make the biochemical profile of the diabetic patient (blood lipids, HbA1c, etc.) as close to the values of non-diabetic people as possible. This is especially true for young patients with many decades of life ahead.
For premium support please call: 800-290-4726 more ways to reach us